Johan, John Drovta, Dighed, Öhd Viktor — CEO
Roles
01.09.2025 – 01.09.2025
Transactions (including via associated entities)
| Date | Issuer | Nature | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 01.09.2025 | Modus Therapeutics Holding AB Stockholm | New shares (subscription) via Karolinska Development AB | 4,891,533 | SEK 3.15 | SEK 15,408,328.95 | ↗ |